MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours
暂无分享,去创建一个
Aniruddha Chatterjee | Michael R Eccles | M. Eccles | A. Chatterjee | M. Sullivan | A. Leichter | Anna L Leichter | Michael J Sullivan
[1] Zhenfeng Duan,et al. MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration , 2011, Molecular Cancer Therapeutics.
[2] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[3] R. Stallings,et al. MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma. , 2011, Cancer letters.
[4] L. Strong,et al. Hepatoblastoma and familial adenomatous polyposis. , 1988, Journal of the National Cancer Institute.
[5] T. Ludwig,et al. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. , 1996, Developmental biology.
[6] M. Garami,et al. microRNA expression might predict prognosis of epithelial hepatoblastoma , 2014, Virchows Archiv.
[7] J Khan,et al. The MYCN oncogene is a direct target of miR-34a , 2008, Oncogene.
[8] Nadav S. Bar,et al. Landscape of transcription in human cells , 2012, Nature.
[9] Yufei Huang,et al. De-Regulated MicroRNAs in Pediatric Cancer Stem Cells Target Pathways Involved in Cell Proliferation, Cell Cycle and Development , 2013, PloS one.
[10] E. Hiyama. Pediatric hepatoblastoma: diagnosis and treatment. , 2014, Translational pediatrics.
[11] Ji Wu,et al. Signaling pathways and preimplantation development of mammalian embryos , 2007, The FEBS journal.
[12] T. McLean,et al. Pediatric genitourinary tumors , 2007, Current opinion in oncology.
[13] Alexander van Oudenaarden,et al. Genome-wide dissection of microRNA functions and cotargeting networks using gene set signatures. , 2010, Molecular cell.
[14] S. Elledge,et al. Dicer is essential for mouse development , 2003, Nature Genetics.
[15] W. Cho. MicroRNAs as therapeutic targets and their potential applications in cancer therapy , 2012, Expert opinion on therapeutic targets.
[16] P. Grundy,et al. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour , 2014, Nature Communications.
[17] W. Xiong,et al. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. , 2011, Omics : a journal of integrative biology.
[18] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[19] T. Gregory,et al. Coincidence, coevolution, or causation? DNA content, cellsize, and the C‐value enigma , 2001, Biological reviews of the Cambridge Philosophical Society.
[20] G. Mirone,et al. The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review). , 2016, Oncology reports.
[21] Y. Yatabe,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.
[22] B. Kushner,et al. Familial neuroblastoma. Case reports, literature review, and etiologic considerations , 1986, Cancer.
[23] W. Cho,et al. The emerging role of miRNAs in combined cancer therapy , 2015, Expert opinion on biological therapy.
[24] S. Hammond,et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells , 2000, Nature.
[25] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[26] Michael A. Beer,et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.
[27] V. Kim,et al. MicroRNA maturation: stepwise processing and subcellular localization , 2002, The EMBO journal.
[28] Kevin B. Jones,et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. , 2012, Cancer research.
[29] U. Kutay,et al. Nuclear Export of MicroRNA Precursors , 2004, Science.
[30] Julia B. Cordero,et al. MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer , 2014, Cancer cell.
[31] C. Thiele,et al. Epigenetic Changes in Pediatric Solid Tumors: Promising New Targets , 2012, Clinical Cancer Research.
[32] Oliver Hofmann,et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. , 2009, Molecular cell.
[33] Zhang Liping,et al. Circulating Liver-Specific miR-122 as a Novel Potential Biomarker for Diagnosis of Cholestatic Liver Injury , 2013, PloS one.
[34] M. Steenman,et al. Genetics of Beckwith‐Wiedemann syndrome‐associated tumors: Common genetic pathways , 2000, Genes, chromosomes & cancer.
[35] W. Weiss,et al. Childhood tumors of the nervous system as disorders of normal development , 2006, Current opinion in pediatrics.
[36] Moshe Oren,et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.
[37] G. Perilongo,et al. Childhood solid tumours: a developmental disorder , 2005, Nature Reviews Cancer.
[38] Anton J. Enright,et al. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. , 2010, Cancer research.
[39] M. Verma,et al. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics , 2016, Cancer medicine.
[40] L. Lim,et al. An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans , 2001, Science.
[41] Wei Wang,et al. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. , 2007, Cancer research.
[42] A. Abarrategi,et al. Bone Environment is Essential for Osteosarcoma Development from Transformed Mesenchymal Stem Cells , 2014, Stem cells.
[43] Sara M. Federico,et al. The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. , 2016, Developmental biology.
[44] Anton J. Enright,et al. Solid Tumors of Childhood Display Specific Serum microRNA Profiles , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[45] R. Stallings,et al. MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics. , 2009, Current pharmaceutical design.
[46] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[47] Nada Jabado,et al. Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR , 2013, Nature Genetics.
[48] V. Kim,et al. The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.
[49] B. Cowan,et al. Pediatric genitourinary tumors. , 1992, Current opinion in oncology.
[50] M. Rivera,et al. Wilms' tumour: connecting tumorigenesis and organ development in the kidney , 2005, Nature Reviews Cancer.
[51] Hsien-Da Huang,et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..
[52] P. Liberski,et al. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma , 2016, PloS one.
[53] M. Esteller,et al. Cancer epigenomics: beyond genomics. , 2012, Current opinion in genetics & development.
[54] Fedor V. Karginov,et al. The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma , 2009, Proceedings of the National Academy of Sciences.
[55] Jian-Fu Chen,et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.
[56] S. Navarro,et al. Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion , 2013, PloS one.
[57] Wanbo Liu,et al. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study , 2016, Pediatric Surgery International.
[58] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[59] M. Cohen,et al. Beckwith-Wiedemann Syndrome: Historical, Clinicopathological, and Etiopathogenetic Perspectives , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[60] Michaela Scherr,et al. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. , 2007, Blood.
[61] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[62] F. Cetani,et al. The microRNA cluster C19MC is deregulated in parathyroid tumours. , 2012, Journal of molecular endocrinology.
[63] Ximing J. Yang,et al. The E2F3-Oncomir-1 axis is activated in Wilms' tumor. , 2008, Cancer research.
[64] V. P. Collins,et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. , 2009, Cancer cell.
[65] A. McMahon,et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. , 2008, Cell stem cell.
[66] S. Kawasaki,et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. , 1998, Cancer research.
[67] M. Soares,et al. Identification of Differentially Expressed MicroRNAs in Osteosarcoma , 2011, Sarcoma.
[68] S. Ohno,et al. So much "junk" DNA in our genome. , 1972, Brookhaven symposia in biology.
[69] M. Esteller,et al. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer , 2011, Oncogene.
[70] Jun Li,et al. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. , 2010, Biochemical and biophysical research communications.
[71] W. Foulkes,et al. Biallelic DICER1 mutations occur in Wilms tumours , 2013, The Journal of pathology.
[72] W. Cho,et al. MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer. , 2016, Current cancer drug targets.
[73] U. Lehmann,et al. Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer , 2008, The Journal of pathology.
[74] Anwar Hossain,et al. Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.
[75] Hiromu Suzuki,et al. DNA methylation and microRNA dysregulation in cancer , 2012, Molecular oncology.
[76] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[77] R. Stallings,et al. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1 , 2013, Molecular Cancer.
[78] Ana Kozomara,et al. miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..
[79] Aniruddha Chatterjee,et al. A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients , 2015, Scientific Reports.
[80] Peter A. Jones,et al. A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.
[81] P. Pagel,et al. MicroRNA‐492 is processed from the keratin 19 gene and up‐regulated in metastatic hepatoblastoma , 2011, Hepatology.
[82] D. Kaufman,et al. Cell cycle control, DNA repair and initiation of carcinogenesis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[83] J. Vandesompele,et al. Identification of miRNAs contributing to neuroblastoma chemoresistance , 2015, Computational and structural biotechnology journal.
[84] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[85] Anton J. Enright,et al. Serum levels of mature microRNAs in DICER1-mutated pleuropulmonary blastoma , 2014, Oncogenesis.
[86] Ana Kozomara,et al. miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..
[87] P. Zamore,et al. ATP Requirements and Small Interfering RNA Structure in the RNA Interference Pathway , 2001, Cell.
[88] Henning Urlaub,et al. Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi , 2002, Cell.
[89] T. Tuschl,et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.
[90] Caterina Giannini,et al. MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. , 2013, Neuro-oncology.
[91] H. Horvitz,et al. MicroRNA Expression in Zebrafish Embryonic Development , 2005, Science.
[92] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[93] Michael H Handler,et al. Survey of MicroRNA expression in pediatric brain tumors , 2011, Pediatric blood & cancer.
[94] R. Russell,et al. Principles of MicroRNA–Target Recognition , 2005, PLoS biology.
[95] Gerald Hoefler,et al. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. , 2012, Carcinogenesis.
[96] Yi Tie,et al. Downregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest , 2008, FEBS letters.
[97] C. Croce,et al. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA , 2012, Proceedings of the National Academy of Sciences.
[98] Frank J. Slack,et al. Aberrant Regulation and Function of MicroRNAs in Cancer , 2014, Current Biology.
[99] B. Cullen,et al. Sequence requirements for micro RNA processing and function in human cells. , 2003, RNA.
[100] R. Stallings,et al. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. , 2007, Cancer research.
[101] A. Donfrancesco,et al. Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM , 2008, PloS one.
[102] B. Cullen,et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.
[103] Kathy Pritchard-Jones,et al. The yin and yang of kidney development and Wilms’ tumors , 2015, Genes & development.
[104] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[105] Dinesh Rakheja,et al. Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours , 2014, Nature Communications.
[106] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[107] F. Zindy,et al. Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression. , 2013, Cancer Research.
[108] D. Merico,et al. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network , 2016, Oncotarget.
[109] Sharon J. Diskin,et al. A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene , 2008, Molecular Cancer Research.
[110] M. Eccles,et al. Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples , 2015, GigaScience.
[111] Yan Zeng,et al. Biogenesis of Mammalian MicroRNAs: A Global View , 2012, Genom. Proteom. Bioinform..
[112] T. Tuschl,et al. Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.
[113] Vincent De Guire,et al. An E2F/miR-20a Autoregulatory Feedback Loop* , 2007, Journal of Biological Chemistry.
[114] T. Yatskievych,et al. MicroRNA expression during chick embryo development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[115] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[116] E. Bertrand,et al. Human let-7 stem-loop precursors harbor features of RNase III cleavage products. , 2003, Nucleic acids research.
[117] M. Shago,et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity , 2014, Acta Neuropathologica.
[118] V. Tarasov,et al. Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest , 2007, Cell cycle.
[119] Kai Li,et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. , 2010, Biochemical and biophysical research communications.
[120] E. Furth,et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.
[121] David Z. Chen,et al. Architecture of the human regulatory network derived from ENCODE data , 2012, Nature.
[122] R. Stallings,et al. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells , 2007, Oncogene.
[123] M. Eccles,et al. DNA methylation and epigenomics: new technologies and emerging concepts , 2015, Genome Biology.
[124] M. O'sullivan,et al. What Do We Know about the Role of miRNAs in Pediatric Sarcoma? , 2015, International journal of molecular sciences.
[125] Ying Feng,et al. Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .
[126] Yu Wei,et al. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. , 2008, Cancer cell.
[127] Claudia Petritsch,et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .
[128] Chih-Hao Chang,et al. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. , 2010, Cancer research.
[129] Hao Zhu,et al. Lin28 sustains early renal progenitors and induces Wilms tumor , 2014, Genes & development.
[130] J Smith,et al. Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.
[131] Michael D. Taylor,et al. MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma* , 2012, The Journal of Biological Chemistry.